+Advanced Search

Synthesis of Chitosan-based Captopril Derivatives and Its in vitro Release
Author:
Affiliation:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
    Abstract:

    In order to overcome the burst release of water-soluble drugs, reduce dosing frequency and improve curative effect,two new bond-linking type drug-loaded control-releasing systems: Chitosan-Captopril and Chitosan-Lysyl-Captopril were synthesized from captopril as a model drug and chitosan as carriers. The products were characterized by IR, 1H NMR and MS. The accumulation of drug release rates of Chitosan-Captopril are 59.2% in PBS buffer (pH=7.4) and 78.4% in HCl-KCl buffer (pH=1.2). The accumulation of drug release rates of Chitosan-Lysyl-Captopril are 55.2% in PBS buffer (pH=7.4) and 76.4% in HCl-KCl buffer (pH=1.2). The results show that the two kinds of drug-loaded systems eliminate the phenomenon of burst releasing and have excellent sustained release properties, which are expected to become the ideal control-releasing system of water-soluble drugs.

    Reference
    Related
    Cited by
Article Metrics
  • PDF:
  • HTML:
  • Abstract:
  • Cited by:
Get Citation
History
  • Received:
  • Revised:
  • Adopted:
  • Online: June 08,2018
  • Published: